51534-77-1

Basic information

• Product Name: TERT BUTYL 4-OXOBUTANOATE
• Synonyms: TERT BUTYL 4-OXOBUTANOATE
• CAS NO: 51534-77-1
• Molecular Formula: C₈H₁₄O₃
• Molecular Weight: 158.19496
• EINECS: -0
• Mol File: 51534-77-1.mol
• Article Data: 14

Chemical Properties

• Boiling Point: 95-105℃ (15 Torr)
• Appearance: /
• Density: 0.979±0.06 g/cm3(Predicted)
• CAS DataBase Reference: TERT BUTYL 4-OXOBUTANOATE(CAS DataBase Reference)
• NIST Chemistry Reference: TERT BUTYL 4-OXOBUTANOATE(51534-77-1)
• EPA Substance Registry System: TERT BUTYL 4-OXOBUTANOATE(51534-77-1)

Safety Data

• Hazardous Substances Data: 51534-77-1(Hazardous Substances Data)

Usage

General Description

Tert butyl 4-oxobutanoate, also known as tert-butyl acetylacetate, is a chemical compound with the molecular formula C8H14O3. It is a colorless liquid with a fruity odor, commonly used as a flavoring agent and fragrance in the food and cosmetic industries. It is also used in the production of pharmaceuticals, agrochemicals, and as a solvent in various chemical reactions. Tert butyl 4-oxobutanoate is known for its low toxicity and high purity, making it a popular choice for a wide range of applications.

Upstream product

• 51534-72-6 4-Methanesulfinyl-4-methylsulfanyl-butyric acid tert-butyl ester 
• 32400-25-2 t-butyl pent-4-enoate 
• 59854-12-5 tert-butyl 4-hydroxybutyrate 
• 15026-17-2 succinic acid mono-tert-butyl ester 
• 540-88-5 acetic acid tert-butyl ester 
• 1663-39-4 tert-Butyl acrylate 
• 201230-82-2 carbon monoxide 
• 1025928-23-7 C₈H₁₃ClO₃ 
• 180858-08-6 N-methoxy-N-methyl-succinamic acid tert-butyl ester 

Downstream Products

• 159116-91-3 4-[(E)-(R)-2-Methoxy-1-phenyl-ethylimino]-butyric acid tert-butyl ester 
• 600708-96-1 (E)-6-oxo-6-[(4S)-(2-oxo-4-phenyl-oxazolidin-3-yl)]hex-4-enoic acid tert-butyl ester 
• 600708-98-3 (2S,3R)-2-azido-3-(4-methoxyphenyl)hexanedioic acid 6-tert-butyl ester 1-methyl ester 
• 600708-99-4 (2S,3R)-2-methoxycarbonylamino-3-(4-methoxyphenyl)hexanedioic acid 6-tert-butyl ester 1-methyl ester 
• 600708-97-2 (4R,5S)-5-azido-4-(4-methoxyphenyl)-6-oxo-6-[(4S)-(2-oxo-4-phenyloxazolidin-3-yl)]hexanoic acid tert-butyl ester 
• 180072-78-0 3-[(2R,3S)-1-(Bis-trimethylsilanyl-methyl)-4-oxo-3-((S)-2-oxo-4-phenyl-oxazolidin-3-yl)-azetidin-2-yl]-propionic acid tert-butyl ester 
• 159117-14-3 (R)-4-(Diethoxy-phosphoryl)-4-((R)-2-methoxy-1-phenyl-ethylamino)-butyric acid tert-butyl ester 
• 58611-60-2 5'-deoxy-5'-[[4-(1,1-dimethylethoxy)-4-oxobutyl]amino]-2',3'-O-(1-methylethylidene)adenosine 

Relevant articles and documents

Synthesis of constrained cycloalkyl analogues of glutamic acid with an ω-phosphonic acid function

A general method based on the sequential reactivities of bis-bromocycloalkenes (3-5) is proposed for the preparation of phosphonocycloalkanes (1a/b-3a/b), representing structural constrained analogues of AP4. For the synthesis of an additional congested A

SUBSTITUTED OXOPYRIDINE DERIVATIVES

The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular vascular disorders, preferably thrombotic

AN IMPROVED HEROIN VACCINE

An improved heroin conjugate vaccine is detailed; to accomplish this task the systematic exploration of twenty vaccine formulations with varying combinations of carrier proteins and adjuvants were undertaken. In regard to adjuvants, a Toll-like receptor 9 (TLR9) agonist and a TLR3 agonist in the presence of alum were explored. The vaccine formulations containing TLR3 or TLR9 agonist alone-elicited strong anti-heroin antibody titers and blockade of heroin-induced antinociception when formulated with alum; however, a combination of TLR3 and 9 adjuvants did not result in improved efficacy. Investigation of stability of the two lead formulations revealed that the TLR9 but not the TLR3 formulation was stable when stored over 30 days. Furthermore, mice immunized with the TLR9 + alum heroin vaccine gained significant protection from lethal heroin doses, suggesting that this vaccine formulation is suitable for mitigating the lethal effects of heroin, even following long-term storage at room temperature.